Shenzhen
300942.SZShenzhen Bioeasy Biotechnology Co., Ltd. Price (300942.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
401,973,412
(0.2778)%Revenue and Profitability
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 87,046,831 | 137,887,788 | 204,933,431 | 239,178,001 | 258,455,671 | 597,539,623 | 686,897,476 | 254,106,487 |
| Net Income | 23,438,995 | 39,292,616 | 73,936,739 | 92,308,448 | 65,445,058 | 236,507,393 | 82,965,490 | -184,907,769 |
| FCF USD | 27,285,676 | 12,785,442 | 47,400,654 | 40,950,633 | -19,042,679 | 175,918,947 | -24,294,058 | -165,894,316 |
| OCF USD | 36,313,100 | 23,602,808 | 57,930,984 | 67,243,603 | 63,793,860 | 255,424,985 | 152,554,531 | -37,249,857 |
Financial Health - DEBT
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.64 | 0.11 | 1.16 | -1.90 |
| D/E | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.04 | 0.12 | 0.41 |
| CA/CL | 3.51 | 5.69 | 6.47 | 8.37 | 6.73 | 5.73 | 3.38 | 5.39 |
| TA/TL | 1.81 | 2.94 | 4.00 | 6.78 | 6.28 | 5.60 | 4.04 | 2.67 |
| Total Debt | 0 | 0 | 0 | 0 | 54,085,995 | 41,117,034 | 119,340,690 | 351,117,014 |
Management Performance
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| ROIC | 15.16% | 26.81% | 28.99% | 16.61% | 11.57% | 23.77% | 7.89% | -10.00% |
| ROE | 42.42% | 34.27% | 33.20% | 17.47% | 11.92% | 25.03% | 8.60% | -21.78% |
| ROA | 0.00% | 22.59% | 24.90% | 14.89% | 10.02% | 20.52% | 6.45% | -13.64% |
| NM % | 26.93% | 28.50% | 36.08% | 38.59% | 25.32% | 39.58% | 12.08% | -72.77% |
| FCF / R% | 0.00% | 9.27% | 23.13% | 17.12% | -7.37% | 29.44% | -3.54% | -65.29% |
| FCF / NI% | 116.50% | 32.56% | 64.13% | 44.37% | -29.10% | 74.39% | -29.39% | 89.68% |
| Operating Margin (OM) | 0.00 | 0.21 | 0.33 | 0.60 | 0.60 | 0.59 | 0.48 | 0.54 |
Per Share
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| EPS | 2.34 | 0.54 | 0.75 | 0.23 | 0.16 | 0.59 | 0.21 | -0.46 |
| SPS | 8.69 | 1.89 | 2.08 | 0.60 | 0.64 | 1.49 | 1.71 | 0.63 |
| OCPS | 3.63 | 0.32 | 0.59 | 0.17 | 0.16 | 0.64 | 0.38 | -0.09 |
| FCPS | 2.72 | 0.18 | 0.48 | 0.10 | -0.05 | 0.44 | -0.06 | -0.41 |
| BVPS | 5.51 | 1.58 | 2.26 | 1.32 | 1.37 | 2.36 | 2.41 | 2.11 |
Per Share - CAGR
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 2.34 | 0.54 | 0.75 | 0.23 | 0.16 | 0.59 | 0.21 | -0.46 |
| CAGR-SPS | 8.69 | 1.89 | 2.08 | 0.60 | 0.64 | 1.49 | 1.71 | 0.63 |
| CAGR-OCPS | 3.63 | 0.32 | 0.59 | 0.17 | 0.16 | 0.64 | 0.38 | -0.09 |
| CAGR-FCPS | 2.72 | 0.18 | 0.48 | 0.10 | -0.05 | 0.44 | -0.06 | -0.41 |
| CAGR-BVPS | 5.51 | 1.58 | 2.26 | 1.32 | 1.37 | 2.36 | 2.41 | 2.11 |